Mylène Gerritsen
0000-0002-1464-9535
Radboud UMC
5 papers found
Refreshing results…
Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia
CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern
RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs
Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1
Missing publications? Search for publications with a matching author name.